This announcement is a separate document:
天津發展：天津力生製藥股份有限公司截至二零二三年三月三十一日止三個月之未經審核財務業績
TIANJIN DEV: Unaudited Financial Results for the three months ended 31 March 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.